ENDRA Life Sciences Inc. Annual Return On Equity in % from 2017 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ENDRA Life Sciences Inc. quarterly/annual Return On Equity history and growth rate from 2017 to 2024.
  • ENDRA Life Sciences Inc. Return On Equity for the quarter ending December 31, 2024 was -211 %, a 16.6% decline year-over-year.
  • ENDRA Life Sciences Inc. annual Return On Equity for 2024 was -211 %, a 16.6% decline from 2023.
  • ENDRA Life Sciences Inc. annual Return On Equity for 2023 was -181 %, a 36.4% decline from 2022.
  • ENDRA Life Sciences Inc. annual Return On Equity for 2022 was -132 %, a 67.4% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -211 -30 -16.6% Jan 1, 2024 Dec 31, 2024
2023 -181 -48.2 -36.4% Jan 1, 2023 Dec 31, 2023
2022 -132 -53.3 -67.4% Jan 1, 2022 Dec 31, 2022
2021 -79.1 +256 +76.4% Jan 1, 2021 Dec 31, 2021
2020 -335 +117 +25.8% Jan 1, 2020 Dec 31, 2020
2019 -451 -80.4 -21.7% Jan 1, 2019 Dec 31, 2019
2018 -371 -257 -225% Jan 1, 2018 Dec 31, 2018
2017 -114 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.